Avidity Biosciences
RNA
#1848
Rank
S$14.29 B
Marketcap
S$92.55
Share price
-0.29%
Change (1 day)
105.23%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: S$14.29 Billion

As of February 2026 Avidity Biosciences has a market cap of S$14.29 Billion. This makes Avidity Biosciences the world's 1848th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$14.29 B2.46%
2025S$13.95 B185.76%
2024S$4.88 B415.99%
2023S$0.94 B-52.14%
2022S$1.97 B31.19%
2021S$1.50 B18.95%
2020S$1.26 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Avidity Biosciences was reported to be:

S$13.94 Billion
by Nasdaq info icon info icon
S$14.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$193.77 B 1,255.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$146.93 B 927.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$2.63 B-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
S$7.55 B-47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.16 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.04 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$13.91 B-2.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$3.91 B-72.58%๐Ÿ‡บ๐Ÿ‡ธ USA